Ad
related to: moderna vaccine
Search results
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 7 hours agovaccine and drugmaker GSK asked the FDA in February to expand approval beyond adults 60 and older,...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 4 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 21 hours agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...
FDA Approves Moderna’s mRESVIA Vaccine | JD Supra
JD Supra· 24 hours agoOn May 31, 2024, Moderna announced that the FDA has approved its respiratory syncytial virus vaccine (“RSV”), mRESVIA (mRNA-1345). The vaccine...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 5 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 1 day agoModerna has a couple of factors to back its strong run. Firstly, the U.S. FDA recently approved ...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 4 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 4 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 5 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
GSK RSV Vaccine Wins US Approval for Younger Age Group
Bloomberg· 9 hours agoHave a confidential tip for our reporters? GSK Plc’s vaccine for respiratory synctial virus was...